Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
53.2M
-
Shares change
-
+251K
-
Total reported value, excl. options
-
$1.8B
-
Value change
-
+$13.8M
-
Put/Call ratio
-
0.33
-
Number of buys
-
121
-
Number of sells
-
-91
-
Price
-
$33.85
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2022
253 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2022.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.2M shares
of 56M outstanding shares and own 95.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.22M shares), VANGUARD GROUP INC (5.68M shares), ARMISTICE CAPITAL, LLC (4.59M shares), DIMENSIONAL FUND ADVISORS LP (2.27M shares), STATE STREET CORP (1.92M shares), GW&K Investment Management, LLC (1.77M shares), Stephens Investment Management Group LLC (1.61M shares), LOOMIS SAYLES & CO L P (1.6M shares), RENAISSANCE TECHNOLOGIES LLC (1.28M shares), and Aristotle Capital Boston, LLC (1.16M shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.